Segment information (Details) |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
|
Dec. 31, 2025
CHF (SFr)
segment
|
Dec. 31, 2024
CHF (SFr)
|
Dec. 31, 2023
CHF (SFr)
|
||||
| Segments | ||||||
| Number of segments | segment | 1 | |||||
| Collaborative research funding | SFr 29,972 | SFr 404,102 | SFr 1,612,953 | |||
| Fair value of services received at zero cost from Neurosterix Group | 141,018 | |||||
| Other service income | 1,870 | 5,940 | 4,235 | |||
| Revenue and other operating income | 172,860 | 410,042 | 1,617,188 | |||
| Long-lived assets | 4,684,148 | 7,136,940 | ||||
| Operating costs | 2,987,458 | 3,165,275 | 3,860,155 | [1] | ||
| Capital expenditure | 0 | 1,273 | 6,842 | |||
| Switzerland | ||||||
| Segments | ||||||
| Long-lived assets | 4,683,813 | 7,136,602 | ||||
| Operating costs | 2,974,125 | 3,129,444 | 3,844,670 | |||
| United States of America | ||||||
| Segments | ||||||
| Operating costs | 8,942 | 31,276 | 11,117 | |||
| France | ||||||
| Segments | ||||||
| Long-lived assets | 335 | 338 | ||||
| Operating costs | 4,391 | 4,555 | 4,368 | |||
| Indivior PLC | ||||||
| Segments | ||||||
| Revenue and other operating income | 29,972 | 404,102 | 1,612,953 | |||
| Neurosterix Group | ||||||
| Segments | ||||||
| Revenue and other operating income | 141,018 | |||||
| Other counterparties | ||||||
| Segments | ||||||
| Revenue and other operating income | SFr 1,870 | SFr 5,940 | SFr 4,235 | |||
| ||||||